Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
72°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Search Is On For Psychedelic Patents & FDA Designations, 3 Companies Share News
January 21, 2023
Tickers
MSSTF
PHRRF
Tags
MSSTF
News
Tryptamines
From
Benzinga
Psychedelics Travel: Clinical-Grade Magic Mushrooms Extract Exported From Southern Africa To UK
January 20, 2023
Tickers
PSYGF
Tags
Markets
GMP Certification
News
From
Benzinga
Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction
January 20, 2023
Tickers
CMND
Tags
Markets
Dr/ Adi Zuloff/Shani
Addictions
From
Benzinga
Psychedelics Market Could Reach $12B By 2029, Says New Report
January 19, 2023
Tickers
CMPS
PHRRF
Tags
CMPS
Psychedelics
Small Cap
From
Benzinga
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
January 18, 2023
Tickers
IXHL
Tags
Generalized Anxiety Disorder
News
IXHL
From
Benzinga
A Psychedelic Program For Treatment Of Stroke: New Clinical Trial Begins Dosing
January 18, 2023
Tickers
AGNPF
DMT
Tags
Psychedelic/Assisted Therapies
Penny Stocks
Benzinga
From
Benzinga
Envisioning A Cocaine-Addiction Treatment: This Next-Gen Psychedelic Shows Positive Results
January 18, 2023
Tickers
CMND
SPRC
Tags
Markets
News
SPRC
From
Benzinga
Psychedelics Company Numinus Wellness Reports Q1 2023 Earnings, Initiatives For Wider Access
January 18, 2023
Tickers
NUMIF
Tags
Market News
Markets
Cannabis
From
Benzinga
Field Trip Health & Wellness Ltd. Launches Online Therapy Covered By Major Insurance Providers
January 16, 2023
Tags
online therapy
Psychedelic/Assisted Therapies
Psychedelics
From
Benzinga
Psychedelics Take Center Stage In Davos: World Economic Forum's Top Minds Gather To Discuss This New Field
January 13, 2023
Tags
News
Markets
Psychedelics
From
Benzinga
6 Psychedelics Companies Take Action: Here Are The Latest, Major Announcements
January 10, 2023
Tickers
BRAXF
FLHLF
HUGE
IWINF
Tags
Legal
HUGE
PSYGF
From
Benzinga
Where Are Psychedelics Headed In 2023? These Two Heavy Hitters Share Their Plans
January 09, 2023
Tickers
CYBN
MNMD
Tags
Generalized Anxiety Disorder
Psychedelics
Cannabis
From
Benzinga
This Original Psychedelic-Based Obesity Treatment Set To First-In-Human Trials
January 06, 2023
Tickers
CMND
SPRC
Tags
News
eating disorders
Markets
From
Benzinga
Treating Binge Eating Disorder With Magic Mushrooms: Phase 2 Clinical Trial Gets Thumbs Up
January 05, 2023
Tickers
TRYPF
Tags
Markets
News
binge eating disorder
From
Benzinga
Guess Which East Coast State Is Now Discussing Legalizing Psychedelics?
January 05, 2023
Tags
Markets
Legal
Linda Rosenthal
From
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
SILO
Market News
Cannabis
From
Benzinga
This IV Psychedelic-Based Compound Completes Phase 2a Trial, Company Gets Extra IP Coverage
December 22, 2022
Tickers
DMTTF
Tags
Psychedelics
major depressive disorder
DMT Clinical Trial
From
Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
December 21, 2022
Tags
psilocybin therapy
Psychedelics
News
From
Benzinga
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
December 19, 2022
Tickers
AWKNF
CMND
FLHLF
MYCOF
Tags
Cannabis
PSYK
Market News
From
Benzinga
EXCLUSIVE: The Psychedelics Debate Is 'Raging' As Filament Debuts Ayahuasca Pill
December 16, 2022
Tickers
CMPS
FLHLF
Tags
News
Ayahuasca
CMPS
From
Benzinga
Psychedelics Company Filament Signs Licensing Deal With Psyence In US, UK And EU
December 15, 2022
Tickers
FLHLF
PSYGF
Tags
Contracts
Offerings
Psychedelics
From
Benzinga
EXCLUSIVE: Ayahuasca Pill Is Officially Here, Filament CEO Discusses Future Plans
December 15, 2022
Tickers
AGNPF
ATAI
FLHLF
Tags
Psychedelic/Assisted Therapies
Global
Penny Stocks
From
Benzinga
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
December 13, 2022
Tickers
CMPS
IWINF
IXHL
NUMIF
Tags
Psychedelics
Small Cap
NUMIF
From
Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
December 12, 2022
Tickers
CMPS
Tags
Benzinga
Psychedelic/Assisted Therapies
Cannabis
From
Benzinga
British Prof. David Nutt Talks About Need For Psychedelic-Assisted Therapy During Australia Visit
December 01, 2022
Tags
News
Psychedelics
Prof/ David Nutt
From
Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
November 29, 2022
Tickers
AWKNF
CMND
CMPS
PSIL
Tags
News
Legal
CMPS
From
Benzinga
Psychedelic-Assisted Therapies: Upcoming Moves In Montana, Colorado And Ontario
November 22, 2022
Tags
News
Ketamine Treatment
Psychedelics
From
Benzinga
Oregon's Opt-Out Results & Future Unfolding Of Psilocybin Service Centers
November 21, 2022
Tags
News
Oregon Psilocybin Services Act
Legal
From
Benzinga
Psychedelics Move Forward In Congress: Sens. Booker And Paul File 'Breakthrough Therapies Act'
November 18, 2022
Tags
Psychedelics
Legal
Congressional Psychedelics Caucus
From
Benzinga
Psychedelics And Treatment-Resistant Depression: An Overview Of COMPASS' Latest Trial Outcomes
November 16, 2022
Tickers
CMPS
Tags
CMPS
News
Markets
From
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.